DiaSorin

With avian influenza A (H5N1) on the rise, the CDC now recommends that healthcare providers accelerate the subtyping of positive influenza A respiratory specimens from hospitalized patients. Check out our recent blog post to learn the importance of influenza A subtyping and how this will impact patient management. Plus, learn the key features of the LIAISON PLEX® Respiratory Flex Assay, which allows you to create custom mini panels from a selection of 19 respiratory pathogens including influenza A subtypes, to meet all your testing needs. Learn more: https://hubs.li/Q03fMGTY0 #InfluenzaA #Avianflu #H5N1 

Join us at the exclusive symposium at ESCMID GLOBAL 2025 “Improving patient management in respiratory infections with innovative and automated diagnostic solutions”. 📅 Sunday, 13 April 2025 🕒 4:15 PM – 5:45 PM CET 📍 Hall 8 – MESSE WIEN, ESCMID GLOBAL Register now: https://lnkd.in/dZNsKtbu #Diasorin #ESCMIDGlobal #ForAHealthierTomorrow ESCMID - European Society of Clinical Microbiology and Infectious Diseases

C. auris presents a significant global challenge, as unidentified asymptomatic carriers can be the source of the spreading for this multidrug-resistant fungi in hospitals, putting vulnerable patients at risk. Identified by the WHO, CDC, and ECDC as a pathogen of critical importance, C. auris is a serious threat to healthcare facilities worldwide, as colonization can lead to severe invasive infections with high mortality rates. The Simplexa™ C. auris Direct kit, now CE-marked in addition to FDA authorization, offers healthcare providers a powerful tool to aid in preventing the spread of this critical pathogen. Delivering timely results, this assay helps to identify colonized patients and enables timely infection control measures.  Visit our website to learn more about how this test can support your efforts in providing optimal patient care:  https://hubs.li/Q03cz8dr0 #Diasorin #Simplexa #LIAISONMDX

Join us at ESCMID 2025 in Vienna from April 11 – 15 and see how cutting-edge, automated solutions are transforming the precision, efficiency and diagnostic certainty in delivering better patient care. Discover our latest advancements, including: ・Advanced automated urinary antigen testing for faster pneumonia detection ・Rapid, reliable solutions for bacterial, viral, and parasitic GI infections ・Latent tuberculosis testing with a standardized and automated workflow ・Comprehensive portfolio to ensure the right test for the right patient at the right time  Register now: https://lnkd.in/dZNsKtbu #Diasorin #ESCMIDGlobal #ForAHealthierTomorrow

The fight against #tuberculosis needs all of us.   On March 24, QIAGEN is bringing together global #TB experts, healthcare leaders and advocates to discuss TB management. Be part of the movement. Join us for expert insights, inspiring stories and powerful discussions.   Register now 👉 https://lnkd.in/e9WfVVk2

Was your lab prepared for the recent surge of Mycoplasma pneumoniae? See how the LIAISON PLEX® Respiratory Flex Assay can help you stay ahead of testing surges. When respiratory testing algorithms only require a small subset of targets, unexpected outbreaks can leave you searching for testing alternatives, such as costly fixed panels or send-outs. The LIAISON PLEX® Respiratory Flex Assay allows you to create custom mini panels for targeted testing algorithms and easily reveal additional targets as needed—enabling flexibility and cost-efficiency during unexpected surges. Learn how to stay ahead of surges and keep costs down with the LIAISON PLEX® Respiratory Flex Assay. https://hubs.li/Q03cpcb_0 #LIAISONPLEX #respiratory #Mycoplasmapneumoniae #flexibletesting

We are excited to share an upcoming webinar on Herpes Simplex Virus (HSV), presented by Dr. Prince, who has over 25 years of experience in developing and interpreting HSV antibody tests from former roles as Scientific Director at Focus Diagnostics and Quest Diagnostics. This session will provide valuable insights into HSV-1 and HSV-2, including transmission, diagnostic methods, and the importance of accurate results.  Join us: https://lnkd.in/gMqTGqdr

We invite you to join our exclusive symposium during ESCMID GLOBAL 2025: “Improving patient management in respiratory infections with innovative and automated diagnostic solutions”. The symposium will provide data and experiences of how recent innovations in molecular and immunoassays can improve patient care by using an automated and standardized workflow to identify respiratory pathogens that provides more accurate results and quickly identifies respiratory pathogens. 📅 Sunday, 13 April 2025 🕒 4:15 PM – 5:45 PM CET 📍 Hall 8 – MESSE WIEN, ESCMID GLOBAL Register now: https://lnkd.in/dG_m3WVt #Diasorin #ESCMIDGlobal #ForAHealthierTomorrow ESCMID - European Society of Clinical Microbiology and Infectious Diseases

Diasorin announces the launch of the Simplexa™ 𝘊. 𝘢𝘶𝘳𝘪𝘴 Direct kit across all countries accepting the CE mark.  This new assay is designed to aid healthcare professionals in identifying patients suspected of 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 𝘢𝘶𝘳𝘪𝘴 colonization to enable infection control in healthcare settings, and prevent potentially deadly infections in vulnerable patients. Read more: https://lnkd.in/dEsS4dur #diasorin #molecular #news

In just 2 weeks, 70% of our Leaders joined the Diasorin Leadership Academy, a global program that supports people in each of the 3 fundamental components of development: being, knowing and acting. A program that contains content designed specifically for Diasorin based on different learning styles: an agile program that takes advantage of technology and social learning. The response of our Leaders is further proof of a Company that focuses on science, knowledge and expertise as drivers of growth. #Diasorin #DiasorinLeadershipAcademy #Science